Literature DB >> 7849384

Primary retroperitoneal synovial sarcoma.

T Miyashita1, T Imamura, Y Ishikawa, K Okinaga, O Kunii, H Miyashita.   

Abstract

We present a patient with primary retroperitoneal synovial sarcoma which showed a monophasic fibrous pattern, the fourth such case to be described, and a review of the literature. Synovial sarcoma cells in the present case were stained positive for cytokeratin and epithelial membrane antigen (EMA), of which histology was differentiated from other spindle cell sarcoma with similar light microscopic features. Retroperitoneal synovial sarcoma is usually treated surgically, however only one of 16 cases identified in the literature survived five years after resection. Due to the high fatality rate, physicians should be alerted to the possibility of this disorder in the differential diagnosis of an abdominal mass.

Entities:  

Mesh:

Year:  1994        PMID: 7849384     DOI: 10.2169/internalmedicine.33.692

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  A Case of Primary Intra-abdominal Synovial Sarcoma.

Authors:  Sayan Sarkar; Shyam Mohan; Reshma Francis; C N Rajesh
Journal:  Indian J Surg Oncol       Date:  2018-05-22

2.  Retroperitoneal synovial sarcoma manifested by obstructive jaundice in an elderly woman: case report.

Authors:  Dae Ho Kim; Kwang Ro Joo; Jae Myung Cha; Hyun Phil Shin; Joung Il Lee; Jae Jun Park; Hyun Soo Kim; Dal Mo Yang
Journal:  Clin Endosc       Date:  2012-11-30

3.  Detection of SYT-SSX fusion transcripts in synovial sarcoma by reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues.

Authors:  S Tsuji; M Hisaoka; Y Morimitsu; H Hashimoto; S Shimajiri; S Komiya; M Ushijima; T Nakamura
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

4.  Management of monophasic synovial sarcoma of the small intestine.

Authors:  Calvin Eriksen; Lance Burns; Angela Bohlke; Salima Haque; Douglas P Slakey
Journal:  JSLS       Date:  2010 Jul-Sep       Impact factor: 2.172

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.